Relevance of the problem and the current situation with infectious morbidity in the Russian ­Federation

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


The article provides an overview of domestic and foreign literary sources devoted to an urgent challenge in modern health care — infectious morbidity. The extraordinary socio-economic importance of infectious diseases at the present stage throughout the world, including in the Russian Federation, based on their global spread and high economic losses associated with disability, treatment costs and anti-epidemic measures. In recent decades, the emergence of previously unknown “new” infectious diseases and the return of “old” infections, many of which pose a high epidemiological danger and are characterized by high mortality, have been noted. Among the significant reasons for the emergence of “new” infections, an increase in infectious diseases, changes in the nature of the course of known diseases, it is necessary to note such reasons as a change in a person's lifestyle and the introduction of new technologies. In Russia, a high incidence of acute respiratory infections is recorded annually. An increase in the incidence of acute intestinal infections of viral etiology and a decrease in the incidence of these diseases of bacterial etiology are noted. An urgent problem is the high level of morbidity and mortality from infection caused by the human immunodeficiency virus, as well as the incidence of chronic viral hepatitis and an increase in mortality from their unfavorable outcomes. Natural focal infections remain an important problem, among which hemorrhagic fever with renal syndrome and tick-borne infections occupy a significant place. The threat of the invasion of infections that cause emergencies in the field of sanitary and epidemiological welfare of the population into the Russian Federation territory remains. Infectious diseases are becoming one of the leading causes of premature mortality in the working-age population. In 2020, the Russian Federation faced the pandemic of the new coronavirus infection COVID-19, which led to high morbidity and mortality. Thus, infectious diseases are an urgent problem for the Russian Federation at the present stage, necessitates the development of a targeted program to reduce morbidity and mortality from infectious diseases.

Full Text

Restricted Access

About the authors

I E Kravchenko

Republican Clinical Hospital for Infectious Diseases named after prof. A.F. Agafonov; Kazan State Medical University

Russian Federation, Kazan, Russia; Kazan, Russia

A M Galieva

Republican Blood Center

Author for correspondence.
Russian Federation, Kazan, Russia

A Yu Vafin

Group of companies “Medsi”

Russian Federation, Moscow, Russia


  1. Maleyev V.V. Problems of infectious pathology at the present stage. Infektsionnye bolezni. 2015; 13 (2): 5–9. (In Russ.)
  2. Yakovlev S.A. Infectious disea­ses as a global problem of our time. The territory of science. 2017; (1): 20–23. (In Russ.)
  3. Polibin R.V., Mindlina A.Y., Gerasimov A.A., Briko N.I. Comparative analysis of mortality from infectious diseases in the Russian Federation and some European countries. Epidemiologiya i vaktsinoprofilaktika. 2017; 16 (3): 4–10. (In Russ.) doi: 10.31631/2073-3046-2017-16-3-4-10.
  4. Galieva A.M., Vafin A.Y., Kravchenko I.I. Impact of resource provision for the regional infection services on public infectious morbidity. Kazan Medical Journal. 2017; 2: 233–238. (In Russ.) doi: 10.17750/KMJ2017-233.
  5. Askhabova L.M., Sabirov L.F., Untilov G.V., Gadzhieva L.A. COVID-2019 in the Republic of Dagestan. Infectious diseases: news, opinions, training. 2020; 9 (4): 46–53. (In Russ.) doi: 10.33029/2305-3496-2020-9-4-46-53.
  6. Savilov E.D., Sinkov V.V., Ogarkov O.B. Estimation of the global movement of infectious diseases, by ­using the techniques of molecular biology. Epidemiologiya i infektsionnye bolezni. Aktual'nye voprosy. 2011; (3): 11–12. (In Russ.)
  7. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2019. State report. M.: The Federal Service for Supervision of Consumer Rights Protection and Human Well-fare. 2020; 142–187 p. (In Russ.)
  8. Kosenko I.M. Prevention and treatment of acute respiratory viral infections. Place of combination drugs. Meditsinskiy sovet. 2014; (15): 72–77. (In Russ.) doi: 10.21518/2079-701X-2014-15-72-77.
  9. Mikheeva A.M., Mikheeva I.V. Ranking dynamics of economic burden of infectious diseases as a criterion of effectiveness of epidemiologic control. Journal of Microbiology, Epidemiology and Immunobiology. 2020; 97 (2): 174–181. (In Russ.) doi: 10.36233/0372-9311-2020-97-2-174-181.
  10. Information on mortality of the population by causes of death in the Russian Federation for January-December 2019. (access date: 03.12.2020).
  11. Ulumbekova G.E. Chto nado delat'. Sostoyanie i predlozheniya: 2019–2024 gg. (What to do. Status and offers: 2019–2024.) M.: GEOTAR-Media. 2019; 68 p. (In Russ.) DOI: 10.33029 / 9704-5417-6-3-HR2019-1-1416.
  12. Ulumbekova G.E. Proposals for health care reform in the Russian Federation after reaching the COVID-19 pandemic peak. Healthcare management: news, views, education. Bulletin of VShOUZ. 2020; 6 (2): 9–26. (In Russ.) doi: 10.24411/2411-8621-2020-12001.
  13. World Health Organization. Global website. (access date: 07.12.2020).
  14. Thompson C.N., Phan My V.T., Hoang N. et al. Prospective Multi-Center Observational Study of children hospitalized with diarrhea in Ho Chi Minh City, Vietnam. Am. Soc. Tropical Med. Hygiene. 2015; 92 (5): 1045–1052. doi: 10.4269/ajtmh.14-0655.
  15. Ampleeva N.P., Uskova Yu.G., Pavelkina V.F. et al. Actual aspects of viral hepatitis B. Modern problems of science and education. 2015; (5): 59–60. (In Russ.)
  16. Yushchuk N.D., Iva­khnenko O.I., Znoyko O.O. et al. Results of the prognosis on the epidemiological situation with hepatitis C depen­ding on the strategy of antiviral therapy. Infectious disea­ses: news, opinions, training. 2020; 9 (4): 60–71. (In Russ.) doi: 10.33029/2305-3496-2020-9-4-60-71.
  17. WHO. Fact sheet №164 hepatitis C. (access date: 05.12.2020).
  18. Dagli O. Comparison of risk factors frequencies of hepatitis C in Two Province. J. Infect. Dis. Prevent. Med. 2016; 4 (2): 1000141. doi: 10.4172/2329-8731.1000141.
  19. Information about the number of diseases. Rosstat. Statistics showcase. (access date: 05.12.2020). (In Russ.)
  20. Kravchenko I.E., Ginyatullin R.R., Amon E.P., Malinnikova E.Yu. State of medical care for patients with chronic hepatitis C in Russian Federation. Infectious diseases: news, opinions, training. 2019; 8 (4): 48–57. (In Russ.) doi: 10.24411/2305-3496-2019-14007.
  21. Lok A.S., McMahon B.J. Chronic hepatitis B. J. Hepatology. 2017; 45 (2): 507–539. doi: 10.1002/hep.21513.
  22. Fatoki B. Understanding the cuses and effects of stigma and discrimination in the lives of HIV people living with HIV/AIDS: qualitative study. J. AIDS Clin. Res. 2016; 7: 635. doi: 10.4172/2155-6113.1000635.
  23. Zhang Z., Guan Q., Yuan H. HIV-1 boadly neutralizing antibodies: identification, development and vaccine evaluation. J. AIDS Clin. Res. 2016; 7: 636. doi: 10.4172/2155-6113.1000636.
  24. Manigold T., Vial. P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. Swiss Med. Wkly. 2014; 144: 1–10. doi: 10.4414/smw.2014.13937.
  25. Sergeeva I.V., Lipnyagova S.V., Shulgina A.I. et al. Hemorrhagic fever with renal syndrome (HFRS) in Krasnoyarsk. Clini­cal case. Modern problems of science and education. 2015; (5): 126. (In Russ.)
  26. Patyashina M.A., Avdonina L.G., Borisova L.O. Organization of monitoring and control of extremely dangerous infectious diseases of imported and local origin on the territory of the Republic of Tatarstan. Prakticheskaya meditsina. 2015; (3-2): 143–147. (In Russ.)
  27. Patyashina M.A., Balabanova L.A. Current problems of surveying sanitary and epidemiological well-being at public events with international participation. Kazan Medical Journal. 2015; 96 (1): 90–95. (In Russ.) doi: 10.17750/KMJ2015-090.
  28. Kravchenko I.E., Lopushov D.V., So­zinova Yu.M. Infektsionnye bolezni, privodyashchie k chrezvychaynym situatsiyam v sfere sanitarno-epidemiologicheskogo blagopoluchiya naseleniya. Uchebnoe posobie dlya vrachey, obuchayushchikhsya po programmam vysshego i dopolnitel'nogo professional'nogo obrazovaniya. (Infectious disea­ses leading to emergency situations in the field of sanitary and epidemiological well-being of the population. Textbook manual for doctors, training for programs of higher and add. prof. education.) Kazan: KSMU. 2018; 207 p. (In Russ.)
  29. Kedrova O.V. Information about the epidemiological situation of dangerous infectious diseases requiring measures for the sanitary protection of the territory in the world, in the CIS countries and the Russian Federation. Infectious diseases: news, opinions, trai­ning. 2015; (3): 13–17. (In Russ.)
  30. Moskvitina E.A., Yanovich E.G., Kurilenko M.L. et al. Cholera: Monitoring of Epidemiological Situation around the World and in Russia (2010–2019). Forecast for 2020. Problemy osobo opasnykh infektsiy. 2020; (2): 38–47. (In Russ.) doi: 10.21055/0370-1069-2020-2-38-47.
  31. Coronavirus. Online Map. (access date: 05.12.2020).
  32. Balykova L.A., Govorov A.V., Vasiliev A.O. et al. Cha­racteristics of COVID-19 and possibilities of early causal therapy. Results of favipiravir use in clinical practice. ­Infektsionnye bolezni. 2020; 18 (3): 30–40. (In Russ.) doi: 10.20953/1729-9225-2020-3-30-40.
  33. Kutyrev V.V., Popova A.Yu., Smolensky V.Yu. et al. Epidemiological features of new coronavirus infection (COVID-19). Communication 1. Modes of implementation of preventive and anti-epidemic measures. Problemy osobo opasnykh infektsiy. 2020; (1): 6–13. (In Russ.) doi: 10.21055/0370-1069-2020-1-6-13.
  34. WHO. Regional Office for Europe. (access date: 05.12.2020).

© 2021 Kravchenko I.E., Galieva A.M., Vafin A.Y.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies